OAM
RPTP

Oxford Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Oxford Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-266,283
Closed -$2.39M – 982
2016
Q3 		$2.39M Buy
+266,283
New +$1.89M 0.07% 368
2015
Q4 		– Sell
-660,856
Closed -$4M – 1071
2015
Q3 		$4M Buy
+660,856
New +$8.1M 0.13% 169

Oxford Asset Management's RPTP Position: Q4 2016 in Review

Oxford Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 266,283 shares — an estimated $2.39M sold.

Oxford Asset Management first reported a position in RPTP in Q3 2015 and held it in 2 quarters. The position peaked at $4M in Q3 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Oxford Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Oxford Asset Management sold 266,283 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.39M.
  • Oxford Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 2 quarters.
  • Oxford Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $4M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Oxford Asset Management's 13F filing for Q4 2016, filed 9 Feb 2017.